Rankings
▼
Calendar
OCGN
Ocugen, Inc.
$578M
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
Gross Profit
$6M
100.0% margin
Operating Income
-$9M
-142.9% margin
Net Income
-$9M
-157.3% margin
EPS (Diluted)
$-0.04
QoQ Revenue Growth
+63.2%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$14M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$65M
Total Liabilities
$24M
Stockholders' Equity
$41M
Cash & Equivalents
$39M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6M
$0
—
Gross Profit
$6M
$0
—
Operating Income
-$9M
-$24M
+64.3%
Net Income
-$9M
-$22M
+56.7%
← FY 2023
All Quarters
Q1 2024 →
OCGN Q4 2023 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena